Assertio Holdings | DEPO - Umsatzkosten

Aktienkurs
11.72
Täglich Wechseln
-0.23 -1.92%
Monatlich
-2.50%
Jährlich
-0.07%
Q1 Prognose
11.30




Umsatzkosten Veränderung Datum
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Assertio Holdings USD 8.89M 2.29M 2024-06
Aurora Cannabis CAD 58.08M 11.99M 2025-09
Cara Therapeutics USD 0 0 2025-03
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 7.97B 689M 2025-12
Knight Therapeutics CAD 47.25M 990K 2024-09
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Omeros USD 33.16M 18.52M 2024-06
Pfizer USD 6.29B 2.12B 2025-12
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12